NCT06217523View on ClinicalTrials.gov

Personalised Hyperlipidaemia Therapies Guided by Pharmacogenomics

NANot yet recruitingINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cardiovascular Diseases
Interventions
OTHER

Pharmacogenomics-directed Hyperlipidaemia Management

Pharmacogenomics-directed Hyperlipidaemia Management

All Listed Sponsors
collaborator

Collabring Pte Ltd

INDUSTRY

lead

National University of Singapore

OTHER